3-hydroxyflavone has been researched along with Cancer of Prostate in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 17 (73.91) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Britton, RG; Brown, K; Denton, R; Gescher, A; Horner-Glister, E; Jenkins, PR; Pomenya, OA; Sale, S; Smith, EE; Steward, WP | 1 |
| Aveta, A; Barone, B; Buonerba, C; Caputo, VF; Cosimato, V; Crocetto, F; Di Lorenzo, G; di Zazzo, E; Ferro, M; Fusco, F; Imbimbo, C; Pandolfo, SD; Scafuri, L; Trama, F | 1 |
| Chen, G; Chen, QH; Lee, M; Li, X; Wang, G; Zhang, Q; Zheng, S | 1 |
| Bakry, SM; Barakat, HH; Hashim, AN; Labib, RM; Linscheid, MW; Moustafa, ES; Nawwar, MA; Singab, AB; Swilam, NF | 1 |
| Chen, G; Chen, QH; Fong, R; Gonzalez, A; Guo, S; Lee, M; Li, X; Rajaram, P; Wang, G; Zhang, C; Zhang, Q; Zheng, S | 1 |
| Adhami, VM; Chiu, SY; Haidar, OM; Joshi, DC; Khan, MI; Lall, RK; Mukhtar, H; Sechi, M; Siddiqui, IA; Syed, DN | 1 |
| Britton, RG; Brown, K; Gescher, AJ; Hill, CU; Howells, LM; Saad, SE; Sale, S | 1 |
| Adhami, VM; Mukhtar, E; Mukhtar, H; Sechi, M | 1 |
| Adhami, VM; Gong, Y; Khan, MI; Lall, RK; Lucey, JA; Mukhtar, H; Syed, DN | 1 |
| Chen, G; Chen, QH; Li, X; Wang, G; Zhang, Q; Zhang, X; Zheng, S | 1 |
| Atala, A | 1 |
| Adhami, VM; Mukhtar, E; Mukhtar, H; Siddiqui, IA; Verma, AK | 1 |
| Abu Zaid, M; Afaq, F; Asim, M; Khan, N; Mukhtar, H | 1 |
| Chien, CS; Huang, JS; Ko, SC; Shen, KH; Shih, YW | 1 |
| Adhami, VM; Khan, N; Mukhtar, H | 1 |
| Afaq, F; Johnson, JJ; Khan, N; Khusro, FH; Mukhtar, H; Suh, Y | 1 |
| Fleshner, N; Haddad, AQ; Klotz, L; Musquera, M; Nelson, C; Saour, B; Venkateswaran, V | 1 |
| Helewski, KJ; Krol, W; Mizgala, E; Szliszka, E | 1 |
| Adhami, VM; Khan, N; Mukhtar, H; Syed, DN | 1 |
| Adams, LS; Hardy, ML; Heber, D; Seeram, NP | 1 |
| Bosetti, C; Bravi, F; Franceschi, S; Gnagnarella, P; La Vecchia, C; Lagiou, P; Montella, M; Negri, E; Parpinel, M; Talamini, R | 1 |
| Mursu, J; Nurmi, T; Pukkala, E; Salonen, JT; Tuomainen, TP; Voutilainen, S | 1 |
| Afaq, F; Mukhtar, H; Suh, Y; Syed, DN | 1 |
4 review(s) available for 3-hydroxyflavone and Cancer of Prostate
| Article | Year |
|---|---|
Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature.
Topics: Animals; Biological Availability; Clinical Trials as Topic; Flavonoids; Flavonols; Humans; Inhibitory Concentration 50; Kaempferols; Male; Models, Animal; Prostatic Neoplasms; Urinary Bladder Neoplasms | 2021 |
Apoptosis by dietary agents for prevention and treatment of prostate cancer.
Topics: Adenocarcinoma; Aged; Animals; Apoptosis; Carotenoids; Catechin; Clinical Trials as Topic; Curcumin; Drug Screening Assays, Antitumor; Flavonoids; Flavonols; Genistein; Humans; Lycopene; Lythraceae; Male; Mice; Mice, Nude; Mice, Transgenic; Middle Aged; Neoplasm Proteins; Pentacyclic Triterpenes; Phytotherapy; Plant Extracts; Prostatic Neoplasms; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2010 |
Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management.
Topics: Animals; Cell Line, Tumor; Flavonoids; Flavonols; Fruit; Humans; Male; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Vegetables | 2012 |
Dietary agents for chemoprevention of prostate cancer.
Topics: Antioxidants; Chemoprevention; Delphinium; Diet; Dietary Supplements; Flavonoids; Flavonols; Humans; Lythraceae; Male; Pentacyclic Triterpenes; Prostatic Neoplasms; Triterpenes | 2008 |
19 other study(ies) available for 3-hydroxyflavone and Cancer of Prostate
| Article | Year |
|---|---|
Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents.
Topics: Antineoplastic Agents; Biological Availability; Cell Line, Tumor; Chemistry Techniques, Synthetic; Drug Stability; Flavonols; Humans; Hydrophobic and Hydrophilic Interactions; Male; Prostatic Neoplasms | 2012 |
3-O-Substituted-3',4',5'-trimethoxyflavonols: Synthesis and cell-based evaluation as anti-prostate cancer agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Flavonols; Humans; Male; Prostatic Neoplasms; Structure-Activity Relationship | 2017 |
A cytotoxic flavonol glycoside from
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Breast Neoplasms; Cell Line, Tumor; Female; Flavonols; Free Radical Scavengers; Glycosides; Humans; Liver Neoplasms; Magnetic Resonance Spectroscopy; Male; MCF-7 Cells; Melaleuca; Phenols; Plant Extracts; Plant Leaves; Prostatic Neoplasms; Spectrometry, Mass, Electrospray Ionization | 2018 |
Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flavonols; Humans; Male; Molecular Structure; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2018 |
YB-1 expression promotes epithelial-to-mesenchymal transition in prostate cancer that is inhibited by a small molecule fisetin.
Topics: Animals; Apoptosis; Blotting, Western; Cell Adhesion; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Flavonoids; Flavonols; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Male; Mice; Mice, Nude; Neoplasm Grading; Phosphorylation; Prostate; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tissue Array Analysis; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Y-Box-Binding Protein 1 | 2014 |
Inhibition of prostate cancer cell growth by 3',4',5'-trimethoxyflavonol (TMFol).
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Flavonols; Humans; Male; Mice; Mice, Nude; Middle Aged; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Dietary flavonoid fisetin binds to β-tubulin and disrupts microtubule dynamics in prostate cancer cells.
Topics: Acetylation; Animals; Binding Sites; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Flavonoids; Flavonols; Male; Microtubule-Associated Proteins; Microtubules; Molecular Docking Simulation; Neoplasm Invasiveness; Nuclear Proteins; Paclitaxel; Prostatic Neoplasms; Protein Binding; Protein Conformation; Protein Processing, Post-Translational; Protein Stability; Signal Transduction; Surface Plasmon Resonance; Time Factors; Tubulin; Tubulin Modulators | 2015 |
Dietary flavonoid fisetin increases abundance of high-molecular-mass hyaluronan conferring resistance to prostate oncogenesis.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Flavonoids; Flavonols; Hyaluronan Receptors; Hyaluronic Acid; Male; Mice; Molecular Weight; Prostatic Neoplasms | 2016 |
A new class of flavonol-based anti-prostate cancer agents: Design, synthesis, and evaluation in cell models.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Design; Flavonoids; Flavonols; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints; Male; Prostatic Neoplasms; Quercetin; Structure-Activity Relationship | 2016 |
Re: Dietary Flavonoid Fisetin Binds to β-Tubulin and Disrupts Microtubule Dynamics in Prostate Cancer Cells.
Topics: Cell Line, Tumor; Flavonoids; Flavonols; Humans; Male; Microtubules; Prostatic Neoplasms; Tubulin | 2016 |
Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Flavonoids; Flavonols; Humans; Male; Mice; Mice, Nude; Neoplastic Stem Cells; Prostatic Neoplasms; Taxoids; Treatment Outcome; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2016 |
A novel dietary flavonoid fisetin inhibits androgen receptor signaling and tumor growth in athymic nude mice.
Topics: Androgen Receptor Antagonists; Anilides; Animals; Anticarcinogenic Agents; Apoptosis; Cell Line, Tumor; Flavonoids; Flavonols; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; Signal Transduction; Tosyl Compounds; Transplantation, Heterologous | 2008 |
Antimetastatic potential of fisetin involves inactivation of the PI3K/Akt and JNK signaling pathways with downregulation of MMP-2/9 expressions in prostate cancer PC-3 cells.
Topics: Cell Line, Tumor; Down-Regulation; Flavonoids; Flavonols; Humans; JNK Mitogen-Activated Protein Kinases; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Metastasis; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction | 2010 |
Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells.
Topics: Autophagy; Cell Death; Cell Line, Tumor; Cell Survival; Down-Regulation; Flavonoids; Flavonols; Humans; Intracellular Signaling Peptides and Proteins; Male; Phagocytosis; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Signal Transduction; TOR Serine-Threonine Kinases | 2010 |
Antiproliferative mechanisms of the flavonoids 2,2'-dihydroxychalcone and fisetin in human prostate cancer cells.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Chalcones; Flavonoids; Flavonols; Gene Expression Profiling; Humans; Male; Mitosis; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms | 2010 |
The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells.
Topics: Apoptosis; Caspase 3; Caspase 8; Cell Line, Tumor; Drug Synergism; Flavonoids; Flavonols; Humans; Male; Membrane Potential, Mitochondrial; NF-kappa B; Prostatic Neoplasms; Receptors, TNF-Related Apoptosis-Inducing Ligand; Recombinant Proteins; TNF-Related Apoptosis-Inducing Ligand | 2011 |
Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines.
Topics: Anthocyanins; Cell Division; Chromatography, High Pressure Liquid; Colonic Neoplasms; Drug Synergism; Flavonoids; Flavonols; Fruit; Humans; Male; Mouth Neoplasms; Neoplasms; Phenols; Plant Extracts; Polyphenols; Prostatic Neoplasms; Tumor Cells, Cultured; Vaccinium macrocarpon | 2004 |
Flavonoids and prostate cancer risk: a study in Italy.
Topics: Aged; Anthocyanins; Body Mass Index; Case-Control Studies; Confidence Intervals; Diet; Flavones; Flavonoids; Flavonols; Humans; Isoflavones; Italy; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Odds Ratio; Prostatic Neoplasms; Risk Factors; Surveys and Questionnaires | 2006 |
Intake of flavonoids and risk of cancer in Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study.
Topics: Anthocyanins; Colorectal Neoplasms; Feeding Behavior; Finland; Flavanones; Flavones; Flavonoids; Flavonols; Follow-Up Studies; Humans; Incidence; Life Style; Lung Neoplasms; Male; Middle Aged; Neoplasms; Odds Ratio; Prospective Studies; Prostatic Neoplasms; Risk Assessment; Risk Factors; Smoking | 2008 |